Suchergebnisse - "Katsarou, Alexia"

PubPharm (31)

1

MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis

enthalten in: Blood advances | 2023

von Katsarou, A. | Trasanidis, N. | Ponnusamy, K. | +12

2

Systems medicine dissection of chromosome 1q amplification reveals oncogenic regulatory circuits and informs targeted therapy in cancer

enthalten in: bioRxiv.org | 2022

von Trasanidis, N. | Katsarou, A. | Ponnusamy, K. | +16

3

Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma

enthalten in: Blood | 2022

von Trasanidis, N. | Katsarou, A. | Ponnusamy, K. | +16

CommentIn: Blood. 2022 Mar 31;139(13):1927-1928. - PMID 35357482

4

The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myeloma

enthalten in: Haematologica | 2022

von Ponnusamy, K. | Tzioni, M. | Begum, M. | +13

5

The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myeloma

enthalten in: bioRxiv.org | 2021

von Ponnusamy, K. | Tzioni, M. | Begum, M. | +13

6

Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma

enthalten in: Nature communications | 2021

von Alvarez-Benayas, J. | Trasanidis, N. | Katsarou, A. | +13

7

Single-cell profiling of human bone marrow progenitors reveals mechanisms of failing erythropoiesis in Diamond-Blackfan anemia

enthalten in: Science translational medicine | 2021

von Iskander, D. | Wang, G. | Heuston, E. | +26

8

Intermittent Energy Restriction, Weight Loss and Cardiometabolic Risk : A Critical Appraisal of Evidence in Humans

enthalten in: Healthcare (Basel, Switzerland) | 2021

von Katsarou, A. | Katsilambros, N. | Koliaki, C.

9

Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia : a structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2021

von Vergis, N. | Phillips, R. | Cornelius, V. | +17

10

Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2021

von Vergis, N. | Phillips, R. | Cornelius, V. | +17